Long -term pigeon and tick treatment gets the approval of the Food and Drug Administration for dogs

Merck Health Treatment and long -acting treatment of Merck Health Company has achieved approval for dogs for at least six months from the Food and Drug Administration (FDA).

The approval of the newly injected treatment, called Bravecto Quantum, has been announced, Federal Agency Thursday.

“The first accredited drug from the Food and Drug Administration (FDA) protects dogs from fleas and ticks for 8 to 12 months,” according to the FDA.

Quantum Bravecto can be used to treat and prevent fleas and abolishing ticks from black legs, American dog ticks, Brown Dog Tills for a year and combat the only star mark versions for eight months in Qualified dogsMerck said animal health.

Merc

The treatment must be determined “only by the licensed veterinarian because the professional experience is required to properly manage the injection, monitor and respond to negative reactions, to advise dog owners regarding use in education dogs and determining the appropriate treatment break (8 for 12 months) based on the types of ticks that the dog is likely to confront” for each FDA.

The active ingredient in Bravecto Quantum is an ISOXAZOLINE category called Fluralner, according to the federal agency.

The Federal Agency noted that Ezoxazolein products were “associated with negative nerve reactions” such as muscle tremors, reeling and attacks in “some” dogs and cats, but are often safe for pets “most” pets “. It is a common category to combat fleas and ticks.

“To be cautious in dogs with a history of seizures or neurological disorders,” Merck said.

Veterinary clinics and hospitals throughout the country are preparing to start providing Bravecto Quantum next month, according to the company.

The world’s first smart dogs use artificial intelligence to track the health of pets, and discover attempts to escape the country’s level of pets.

Description of the product as “served for a longer period Protecting fleas and ticks From any other system product currently on the market. ”

“Approval of Bravico is a quantity that sets a new standard in caring for pets by providing veterinarians and pets with a safe and effective option when it comes to fleas and dog prevention,” Christine Royal, CEO of Merck in the field of animal health said in a statement.

The QUANTUM has obtained approval in more than 50 countries, according to Merck Health Health.

Merck Health Health is an animal -focused part within the giant Merck company. Merck also makes many medications and vaccines for humans.

Get Fox Business on the Go by clicking here

the Pharmaceutical Company A 15.53 billion dollar sales were born during the first quarter, approximately 1.6 billion dollars in animal health. Meanwhile, his classistic net income was $ 5.08 billion.

Merck is scheduled to lead the financial results for the second quarter at the end of this month.